NCT00839631 - Dose Escalation Study of EC D-3263 HCl in Advanced Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

April 30, 2012

Conditions

Solid Tumors

Interventions

DRUG

EC D-3263 HCl

EC D-3263 HCl, capsules, 50 mg. Oral administration. Dose escalation cohorts (cycle one: single dose on Day 1, daily doses on day 8-28; subsequent cycles: 1 week drug holiday followed by 3 weeks of daily dosing). Expansion Cohort: daily dosing for 28 days followed by a single 7 day drug holiday (Cycle 1), continuing thereafter with daily dosing.

Trial Locations (1)

78229

South Texas Accelerated Research Therapeutics (START), San Antonio